SOBRsafe Reports Third Quarter 2025 Results

SOBRsafe Reports Third Quarter 2025 Results DENVER, November 12, 2025 – SOBR Safe, Inc. (Nasdaq: SOBR) (“SOBRsafe” or the “Company”), the leader in next-generation alcohol monitoring and detection technology, is reporting financial and operating results for the third quarter ended September 30, 2025. Third Quarter 2025 Operational and Financial Highlights · Revenue increased 136.1 % year-over-year. · Sold 277 SOBRsureTM GEN 2 devices, up 55.6% from the second quarter of 2025. · SOBRsure TM GEN 2 related hardware and software revenues contributed 80.7% of total revenue during the quarter and 78.0% year to date. · Annual recurring revenue from software subscription sales at quarter-end is $152.2 thousand increasing by $57.4 thousand during the quarter, or 60.5%. · Launched additional targeted marketing campaigns for key national initiatives such as Recovery Month in September as well as two new segment specific campaigns to expand brand awareness outside addiction recovery use cases. · Refined the Company’s marketing strategy to emphasize high-performing regions and new direct-to-consumer audiences, resulting in shorter sales cycles, higher conversion rates, and a 266% quarter-over-quarter increase in website traffic. · Achieved the highest monthly sales in Company history in October, supported by the addition of two new channel partners, and subsequently received the largest SOBRsure™ GEN 2 device order to date in November. “The third quarter marked another period of consistent operational progress and growing commercial traction,” said SOBRsafe CEO David Gandini. “Since the launch of our SOBRsure™ GEN 2 device and reinvigorated brand platform late last year, we have seen steady month-over-month sales growth, with October representing our strongest sales month to date. Online sales remain a key contributor, supported by our newly enhanced e-commerce platform and more effective digital engagement strategy. We recently secured two new channel partners and continue to see expanding interest from organizations seeking discreet, reliable alcohol monitoring and detection solutions. Across both behavioral health and consumer markets, we are seeing increasing validation that our technology solutions and brand are resonating. “Our marketing investments are driving measurable results, with website traffic up 266% and conversion rates improving as we refine our campaigns and segmentation. We have a clear end-of-year marketing plan that includes targeted messaging, influencer partnerships, and expanded social media activity designed to strengthen awareness heading into the critical holiday and “dry” January periods. The feedback from both consumers and behavioral health customers reinforces that our brand is gaining recognition and trust, and that our focused strategy is translating into sustained sales momentum. “While still in the early stages of commercialization, we are executing with focus and alignment around our long-term strategic objectives. SOBRsafe is building meaningful brand awareness and industry credibility, validated by early interest from oversight organizations, healthcare networks, and behavioral health providers. Our priorities are concentrated around accelerating revenue growth across the behavioral health and consumer markets, cultivating global pilot programs that can evolve into licensing partnerships, and expanding our sales organization to support these initiatives. At the same time, we are strengthening our in-house technology expertise, enhancing our software capabilities through advanced analytics and machine learning, and reimagining our SOBRcheck™ and SOBRsure™ products for broader adoption in early 2027. With these initiatives underway, we believe SOBRsafe is well positioned to convert our growing brand recognition and technology leadership into sustainable, scalable growth.” Third Quarter 2025 Financial Results Revenue in the third quarter of 2025 increased 136.1% to $108.9 thousand compared to $46.1 thousand for the same period in 2024 and increased 4.5% compared to the second quarter of 2025. The year-over-year and sequential growth was primarily attributable to increased sales for the Company’s SOBRsureTM device and SOBRsureTM software subscriptions. Gross profit in the third quarter of 2025 increased to $37.9 thousand compared to $30.1 thousand for the same period in 2024. Gross margin was 34.8% in the third quarter of 2025, compared to 65.3% in the third quarter of 2024. The year-over-year decline in margin was largely due to strategic price reductions to the Company’s SOBRsureTM device and software subscriptions to expand its customer base as well as higher costs associated with product replacements to enhance device quality. Operating expenses in the third quarter of 2025 were $2.3 million compared to $1.9 million for the prior year period. The increase was reflective of additional general and administrative costs associated with the Company’s expanded head count, businesses development costs, and increased marketing efforts. Net loss in the third quarter of 2025 was $(2.2) million, or $(1.44) per diluted share, compared to a net loss of $(1.8) million, or $(58.26) per diluted share, for the prior year period. Note, the earnings per diluted share in the prior year period has been adjusted for the 1-for-110 and 1-for-10 reverse splits of the Company’s common stock on the Nasdaq Capital Markets effected October 2, 2024 and April 4, 2025, respectively. The increase in net loss was primarily attributable to higher operating costs, partially offset by reduced stock-based compensation, and research and development expenses. Cash and cash equivalents were $4.7 million at September 30, 2025, compared to $8.4 million at December 31, 2024. About SOBRsafe™ Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit www.sobrsafe.com. Safe Harbor Statement Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 and the Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this presentation. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at www.sec.gov. Company Contact: IR@sobrsafe.com Investor Relations Contact: Scott Liolios or Taylor Stadeli Gateway Group 949-574-3860 SOBR@gateway-grp.com 2 SOBR SAFE, INC. CONDENSED CONSOLIDATED BALANCE SHEETS September 30, December 31, 2025 2024 ASSETS (Unaudited) Current assets Cash $ 4,711,664 $ 8,384,042 Accounts receivable, net 32,384 24,460 Inventory 142,230 224,875 Prepaid expenses 313,521 192,637 Other current assets 19,161 46,060 Total current assets 5,218,960 8,872,074 Property and equipment, net 36,264 - Intellectual technology, net 1,798,867 2,087,965 Operating lease right-of-use assets, net 108,769 183,737 Other assets 27,427 27,427 Total Assets $ 7,190,287 $ 11,171,203 LIABILITIES & STOCKHOLDERS' EQUITY Current liabilities Accounts payable $ 394,978 $ 422,557 Accrued expenses 360,012 498,128 Accrued interest payable 113,422 105,501 Deferred revenue 10,092 - Operating lease liabilities, current portion 121,584 111,303 Notes payable - related parties, net 11,810 11,810 Notes payable - non-related parties, net 210,664 127,590 Total current liabilities 1,222,562 1,276,889 Operating lease liabilities, less current portion - 91,993 Total Liabilities 1,222,562 1,368,882 Commitments and contingencies Stockholders' Equity Common stock, $0.00001 par value; 100,000,000 shares authorized, 1,516,238 and 936,926 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 15 94 Treasury stock, at cost; 17 and 16 shares as of September 30, 2025 and December 31, 2024, respectively (38,015 ) (38,015 ) Additional paid-in capital 110,499,728 108,222,324 Accumulated deficit (104,440,303 ) (98,328,395 ) Total SOBR Safe, Inc. stockholders' equity 6,021,425 9,856,008 Noncontrolling interest (53,700 ) (53,687 ) Total Stockholders' Equity 5,967,725 9,802,321 Total Liabilities and Stockholders' Equity $ 7,190,287 $ 11,171,203 3 SOBR SAFE, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS For The Three Months Ended September 30, For The Nine Months Ended September 30, 2025 2024 2025 2024 (Unaudited) (Unaudited) (Unaudited) (Unaudited) Revenues $ 108,893 $ 46,129 $ 299,738 $ 148,310 Cost of goods and services 71,026 15,992 151,023 81,929 Gross profit 37,867 30,137 148,715 66,381 Operating expenses: General and administrative 2,117,641 1,499,296 5,756,138 4,310,791 Stock-based compensation expense 115,250 184,243 370,180 584,551 Research and development 30,102 194,466 269,701 604,927 Total operating expenses 2,262,993 1,878,005 6,396,019 5,500,269 Loss from operations (2,225,126 ) (1,847,868 ) (6,247,304 ) (5,433,888 ) Other income (expense): Other income, net 47,459 12,566 200,889 46,978 Notes payable – conversion expense - - - (585,875 ) Interest expense (8,961 ) (5,908 ) (14,753 ) (451,720 ) Total other income (expense), net 38,498 6,658 186,136 (990,617 ) Loss before provision for income taxes (2,186,628 ) (1,841,210 ) (6,061,168 ) (6,424,505 ) Provision for income taxes - - - - Net loss (2,186,628 ) (1,841,210 ) (6,061,168 ) (6,424,505 ) Net loss attributable to noncontrolling interest 4 4 13 13 Net loss attributable to SOBR Safe, Inc. $ (2,186,624 ) $ (1,841,206 ) $ (6,061,155 ) $ (6,424,492 ) Deemed dividends related to Convertible Debt Warrants down round provision - - (1,833 ) (23,270 ) Deemed dividends related to 2022 PIPE Warrants down round provision - - (1,547 ) (46,875 ) Deemed dividends related to Original Warrants and New Warrants down round provision - - - (1,455,805 ) Deemed dividends related to 2024 PIPE Warrants round down provision - - (47,373 ) - Warrant Inducement transactional costs - - - (341,297 ) Net loss attributable to common stockholders $ (2,186,624 ) $ (1,841,206 ) $ (6,111,908 ) $ (8,291,739 ) Basic and diluted loss per common share $ (1.44 ) $ (58.26 ) $ (4.21 ) $ (353.65 ) Weighted average number of common shares outstanding 1,516,238 31,605 1,451,713 23,446 4 SOBR SAFE, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS For The Nine Months Ended September 30, 2025 2024 (Unaudited) (Unaudited) Operating Activities: Net loss $ (6,061,168 ) $ (6,424,505 ) Adjustments to reconcile net loss to net cash used in operating activities: Amortization and depreciation 291,006 289,098 Amortization of debt discounts - 237,250 Non-cash lease expense 74,968 67,315 Non-cash interest expense 7,921 336,510 Non-cash conversion expense - 585,875 Bad debt expense 9,490 202 Stock-based compensation expense 370,182 584,551 Changes in assets and liabilities: Accounts receivable (17,414 ) (20,573 ) Inventory 82,645 72,798 Prepaid expenses 152,161 86,566 Other assets 26,899 (21,534 ) Accounts payable (27,579 ) (200,355 ) Accrued expenses (168,017 ) (306,941 ) Accrued interest payable - (126,086 ) Deferred revenue 10,092 - Operating lease liabilities (81,712 ) (71,199 ) Net cash used in operating activities (5,330,526 ) (4,911,028 ) Investing Activities: Purchase of property and equipment (38,172 ) - Net cash used in investing activities (38,172 ) - Financing Activities: Repayments of notes payable - non-related parties (160,070 ) - Proceeds from exercise of stock warrants 3,680,411 2,786,174 Payment of transactional costs for exercise of warrants (184,021 ) (360,756 ) Payment of 2024 PIPE Warrant True-up Payment (1,640,000 ) - Net cash provided by financing activities 1,696,320 2,425,418 Net Change In Cash (3,672,378 ) (2,485,610 ) Cash At The Beginning Of The Period 8,384,042 2,790,147 Cash At The End Of The Period $ 4,711,664 $ 304,537 Schedule Of Non-Cash Investing And Financing Activities: Deemed dividends related to Convertible Debt Warrants down round provision $ (1,833 ) $ 23,270 Deemed dividends related to 2022 PIPE Warrants down round provision $ (1,547 ) $ 46,875 Deemed dividends related to Original Warrants and New Warrants down round provision $ - $ 1,455,805 Deemed dividends related to 2024 PIPE warrants round down provision $ (47,373 ) $ - Non-related party debt converted to capital $ - $ 2,879,279 Warrant inducement transactional costs $ - $ 341,297 Financing of prepaid insurance premiums $ - $ (161,896 ) Supplemental Disclosure: Cash paid for interest $ 6,833 $ 266 Cash paid for income taxes $ - $ - 5